What is Adagene Inc (ADAG) stock price today?

Adagene Inc (ADAG) currently trades at $3.55 per share. The stock has a market capitalization of $234.56M and a P/E ratio of —x.

Is ADAG stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Adagene Inc has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 5/9 and Altman Z-Score is -4.14.

What is Adagene Inc's revenue and earnings?

Adagene Inc has trailing twelve-month (TTM) revenue of $7.67M with profit margins of -229.60%. Earnings per share (EPS) is $-0.37.

Is Adagene Inc financially healthy?

Adagene Inc's Piotroski F-Score is 5/9 (moderate financial health). The Altman Z-Score of -4.14 places it in the distress.

ADAG

Adagene Inc

NASDAQ: ADAG · HEALTHCARE · BIOTECHNOLOGY

$3.55

+0.57% today

Updated 2026-04-29

Market cap

$234.56M

P/E ratio

—

P/S ratio

30.58x

EPS (TTM)

$-0.37

Dividend yield

—

52W range

$1 – $5

Volume

0.3M

Market cap

$234.56M

P/E ratio

—

P/S ratio

30.58x

EPS (TTM)

$-0.37

Dividend yield

—

52W range

$1 – $5

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

6.5

Quality

2.0

Profitability

5.0

Valuation

C+

5/9

Piotroski F-Score

Moderate

-4.1

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$9.40

+164.79%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 7,333.00% QoQ

+ Debt/equity 0.18x — low leverage

Risks

- Altman Z -4.14 — distress zone

- Thin margins at -229.60%

- Negative free cash flow $-4.56M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$9.29M	$18.11M	$103204.00	$7.67M	$7.67M
Net income	$-79.97M	$-18.95M	$-33.42M	$-17.61M	$-4.14M
EPS	—	—	—	—	$-0.37
Free cash flow	$-49.30M	$-28.54M	$-29.73M	$-15.67M	$-4.56M
Profit margin	-860.59%	-104.61%	-32,386.45%	-229.56%	-229.60%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ADAG	$234.56M	22	5.3	2.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Adagene Inc trades at $3.55. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -4.14, it sits in the distress. TTM revenue stands at $7.67M. with profit margins at -229.60%.

Frequently asked questions

What is Adagene Inc's stock price?

Adagene Inc (ADAG) trades at $3.55.

Is Adagene Inc overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Adagene Inc (ADAG)?

The analyst target price is $9.40, representing +164.8% upside from the current price of $3.55.

What is Adagene Inc's revenue?

TTM revenue is $7.67M.

Piotroski F-Score?

5/9 — moderate financial health.

Altman Z-Score?

-4.14 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.adagene.com

Quick metrics

P/S ratio30.58x

ROE-34.40%

Beta0.59

50D MA$3.63

200D MA$2.43

Shares out0.07B

Float0.04B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ADAG vs LLY →ADAG vs JNJ →ADAG vs ABBV →Stock screener →